FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100279269> ?p ?o ?g. }

• W2100279269 endingPage "716" @default.
• W2100279269 startingPage "714" @default.
• W2100279269 abstract "In this issue, there is an important article by Abdulla and Johns (Abdulla & Johns 2014), which details a previously unknown role of brain nitric oxide (NO) in the modulation of central angiotensin II (type 2) receptor (AT2 receptor) stimulated high-pressure baroreflex control of heart rate (HR) and renal sympathetic nerve activity (RSNA). The authors provide the first experimental evidence that there is a facilitatory role for brain AT2 receptors in the high-pressure baroreflex regulation of RSNA and HR that is dependent of the presence of an operational central nitric oxide/nitric oxide synthase (NOS) system. These findings deepen our understanding of the interplay between brain NO and the angiotensin AT2 receptor system that acts to influence the cardiac and renal sympathetic baroreflex. Collectively, the presented studies highlight the complex interactions between brain angiotensin II (type 1) (AT1 receptor) (inhibitory) and angiotensin II (type 2) (stimulatory) receptors on the baroreflex response that is dependent on the actions of NO within the central nervous system (CNS). Owing to the significant adverse health impact of an impaired baroreflex response (Gerristen et al. 2001), studies such as these, which enhance our understanding of the baroreflex, have potential high significance for human health. Multiple studies have demonstrated an action of brain NO, likely as a neurotransmitter or neuromodulator, on central sympathetic outflow and systemic cardiovascular function. Importantly, NOS activity within the nucleus tractus solitarius (NTS), which evokes depressed baroreflex regulation of blood pressure and increased central sympathetic outflow, is established as a contributing factor in the neural mechanisms underlying the development of hypertension (Chan & Chan 2014). Further, a role of endogenous NO in the stimulation of RSNA via angiotensin AT1-receptors located within the NTS has been reported (Eshima et al. 2000). Recent immunolabeling studies have provided evidence that in neurones of the NTS AT2 receptors are required to facilitate enhanced NO production following AT1 receptor antagonism – suggesting a potential interaction between AT1 and AT2 receptors upon NO (Wang et al. 2012). Functional in-vitro studies have also demonstrated that NO blockade is able to inhibit the angiotensin AT2 stimulated facilitation of neuronal membrane potassium currents (Gao & Zucker 2010), data which supports a potential interaction between NO and the AT2 receptor. A recent paper from the lab of Dr Johns provided in-vivo evidence, generated in rats, that in response to the physiological challenge of an acute isotonic saline volume expansion, there are significant, but independent, roles of both angiotensin AT2 receptors and NO in the sympathoinhibitory renal nerve response evoked by this stimuli (Abdulla & Johns 2013a). The current studies (Abdulla & Johns 2014) presented in this issue of Acta Physiologica extend their previous work to examine the role(s) of CNS-generated NO and brain angiotensin AT2 receptors on the high-pressure arterial baroreceptor regulation of renal sympathetic nerve activity and heart rate. The robust approach utilized by Abdulla and Johns has yielded several novel findings. A key finding of the current work is that under basal conditions both endogenous brain NO and angiotensin AT2 receptors contribute significantly to the high-pressure arterial baroreceptor control of RSNA and HR. Inhibition of CNS NO production by central administration of L-NAME enhanced cardiac and renal baroreflex sensitivity. These data provide evidence that under normal conditions endogenous CNS NO, potentially via acting as a neurotransmitter or modulator, provides an inhibitory action on the baroreflex regulation of RSNA and HR. Conversely, the pharmacological blockade of central AT2 receptors attenuated baroreflex control of RSNA and heart rate – indicating that endogenous AT2 receptor activity contributes to the normal baroreflex regulation of RSNA and HR. A role of AT2 receptors in baroreflex regulation of RSNA and HR, as demonstrated by the data presented by Abdulla and Johns, is supported by localization of AT2 receptors in known neural control centres, for example, RVLM, NTS, SFO (Gao et al. 2008) and evidence that AT2 receptor activation produces sympatho-inhibition (Gao et al. 2008, Gao & Zucker 2010). The second major finding of the reported studies is that exogenous stimulation of angiotensin AT2 receptors, by i.c.v. administration of the AT2 agonist CGP42112, significantly increased the sensitivity of the renal and cardiac baroreflex versus a vehicle treatment. Critically, the authors also demonstrate that this enhanced baroreflex sensitivity following AT2 receptor activation is dependent on the presence of a functional central NO system. It should be noted that these data are in contrast to a previous report that i.c.v. CGP42112 decreases cardiac baroreflex sensitivity in rats (Oliveira et al. 1996). However, the present findings are supported by several lines of evidence including (i) microinjection of CGP42112 into the rostralventerolateral medulla of rats evokes global sympatho-inhibiton and a decrease in RSNA (Gao et al. 2008) and, (ii) angiotensin AT2 receptor knock-out mice exhibit a greater AT1 receptor-mediated pressor response than wild-type mice, indicating the role of AT2 receptors in buffering the pressor response to AT1 activation (Gross et al. 2002). Further support for the key role of brain NO in AT2 receptor signalling is provided by evidence that antagonism of central AT1 receptors resulted in a significant increase in the sensitivity of the cardiac and renal baroreflex that was dependent on the actions of NO within the brain (Abdulla & Johns 2014). These data support the hypothesis that exogenous activation of brain AT2 receptors impacts the baroreflex through a downstream pathway that requires a functional NO system. The question of whether an imbalance in the endogenous activity of central angiotensin AT1 and AT2 receptors adversely affects the arterial baroreceptor response via a mechanism involving NO in disease states which feature autonomic dysregulation (e.g., heart failure, hypertension) is still to be definitively answered. The data generated in this study provide direct evidence of a role central of NO in mediating brain angiotensin AT2 receptor regulation of the cardiac and renal sympathetic baroreflex. This is evidenced by (i) the increased sensitivity of high-pressure baroreceptors following AT2 receptor activation or AT1 receptor antagonism and (ii) attenuation of the increased baroreflex sensitivity of high-pressure baroreceptors following L-NAME administration. The locus of the reported interaction of NO and AT2 receptors within the CNS remains to be established, and it is highly likely the actions of both NO and AT2 receptors upon the cardiac and renal sympathetic baroreflex will depend on the neural circuitry within the brain sites in which these systems are activated - as noted by the authors. Exploring the interactions of central AT2 receptors and NO on the renal baroreflex in animal models in which there is an impaired baroreflex response (e.g., the spontaneously hypertensive rat, heart failure models), and determination of the endogenous levels/activity of angiotensin AT1 & AT2 receptors and NO throughout the CNS in these phenotypes, will provide important insight into the implications of the findings reported in this issue of Acta Physiologica (Abdulla & Johns 2014). Collectively, the findings presented by Abdulla and Johns increase our understanding of the actions of brain angiotensin AT2 receptors to influence the regulation of sympathetic outflow to the kidneys. Owing to the critical importance of the renal sympathetic nerves on long-term blood pressure regulation (Abdulla & Johns 2013b) and fluid and electrolyte homeostasis in multiple disease states (e.g., hypertension, heart failure, renal failure), these findings may shed important insight into baroreflex impairment that is present as part of the pathophysiology of multiple cardiovascular diseases. There are no conflicts of interests. R.D.W. is supported by NIH grants R01HL107330 and K02HL112718." @default.
• W2100279269 created "2016-06-24" @default.
• W2100279269 creator A5018177312 @default.
• W2100279269 date "2014-02-23" @default.
• W2100279269 modified "2023-09-25" @default.
• W2100279269 title "Angiotensin AT2 receptors and the baroreflex control of renal sympathetic nerve activity" @default.
• W2100279269 cites W1563044851 @default.
• W2100279269 cites W1975420023 @default.
• W2100279269 cites W2026976389 @default.
• W2100279269 cites W2090604693 @default.
• W2100279269 cites W2135905917 @default.
• W2100279269 cites W2140217309 @default.
• W2100279269 cites W2154942675 @default.
• W2100279269 cites W2321252797 @default.
• W2100279269 cites W2328109237 @default.
• W2100279269 doi "https://doi.org/10.1111/apha.12240" @default.
• W2100279269 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4110512" @default.
• W2100279269 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24447624" @default.
• W2100279269 hasPublicationYear "2014" @default.
• W2100279269 type Work @default.
• W2100279269 sameAs 2100279269 @default.
• W2100279269 citedByCount "1" @default.
• W2100279269 countsByYear W21002792692015 @default.
• W2100279269 crossrefType "journal-article" @default.
• W2100279269 hasAuthorship W2100279269A5018177312 @default.
• W2100279269 hasBestOaLocation W21002792691 @default.
• W2100279269 hasConcept C126322002 @default.
• W2100279269 hasConcept C134018914 @default.
• W2100279269 hasConcept C169760540 @default.
• W2100279269 hasConcept C170493617 @default.
• W2100279269 hasConcept C191237925 @default.
• W2100279269 hasConcept C2776533406 @default.
• W2100279269 hasConcept C2777953023 @default.
• W2100279269 hasConcept C2908929049 @default.
• W2100279269 hasConcept C3020789104 @default.
• W2100279269 hasConcept C71924100 @default.
• W2100279269 hasConcept C84393581 @default.
• W2100279269 hasConcept C86803240 @default.
• W2100279269 hasConceptScore W2100279269C126322002 @default.
• W2100279269 hasConceptScore W2100279269C134018914 @default.
• W2100279269 hasConceptScore W2100279269C169760540 @default.
• W2100279269 hasConceptScore W2100279269C170493617 @default.
• W2100279269 hasConceptScore W2100279269C191237925 @default.
• W2100279269 hasConceptScore W2100279269C2776533406 @default.
• W2100279269 hasConceptScore W2100279269C2777953023 @default.
• W2100279269 hasConceptScore W2100279269C2908929049 @default.
• W2100279269 hasConceptScore W2100279269C3020789104 @default.
• W2100279269 hasConceptScore W2100279269C71924100 @default.
• W2100279269 hasConceptScore W2100279269C84393581 @default.
• W2100279269 hasConceptScore W2100279269C86803240 @default.
• W2100279269 hasIssue "4" @default.
• W2100279269 hasLocation W21002792691 @default.
• W2100279269 hasLocation W21002792692 @default.
• W2100279269 hasLocation W21002792693 @default.
• W2100279269 hasLocation W21002792694 @default.
• W2100279269 hasOpenAccess W2100279269 @default.
• W2100279269 hasPrimaryLocation W21002792691 @default.
• W2100279269 hasRelatedWork W1971613811 @default.
• W2100279269 hasRelatedWork W2034583712 @default.
• W2100279269 hasRelatedWork W2047925791 @default.
• W2100279269 hasRelatedWork W2063619316 @default.
• W2100279269 hasRelatedWork W2074821979 @default.
• W2100279269 hasRelatedWork W2089589096 @default.
• W2100279269 hasRelatedWork W2137237120 @default.
• W2100279269 hasRelatedWork W2151139437 @default.
• W2100279269 hasRelatedWork W2162471541 @default.
• W2100279269 hasRelatedWork W2169225653 @default.
• W2100279269 hasVolume "210" @default.
• W2100279269 isParatext "false" @default.
• W2100279269 isRetracted "false" @default.
• W2100279269 magId "2100279269" @default.
• W2100279269 workType "article" @default.